CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL

NCT05270772 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

9

Enrollment

OTHER

Sponsor class

Conditions

CD19+ Relapse/Refractory B-ALL

Interventions

BIOLOGICAL: CAR-T-19 Cells

Sponsor

Chinese PLA General Hospital